Silo Pharma Inc (SILO) — Cash Flow-to-Debt Ratio
Silo Pharma Inc (SILO) has a Cash Flow-to-Debt Ratio of -0.62x as of March 2026, meaning its operating cash flow of $-822.62K could theoretically repay -1% of its total liabilities ($1.34 Million) in one year. Explore SILO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Silo Pharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Silo Pharma Inc across 15 annual periods. Also explore Silo Pharma Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Silo Pharma Inc (2011–2025)
Year-by-year debt coverage analysis for Silo Pharma Inc. For market capitalisation and broader financial context, see market cap of Silo Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.59x | $-4.66 Million | $1.30 Million | ▼ -122.4% |
| 2024 | -1.61x | $-3.83 Million | $2.38 Million | ▲ +21.5% |
| 2023 | -2.05x | $-3.22 Million | $1.57 Million | ▲ +23.5% |
| 2022 | -2.69x | $-3.50 Million | $1.30 Million | ▼ -68.4% |
| 2021 | -1.60x | $-2.28 Million | $1.43 Million | ▲ +79.9% |
| 2020 | -7.93x | $-1.16 Million | $145.97K | ▼ -415.6% |
| 2019 | -1.54x | $-794.32K | $516.74K | ▼ -352.6% |
| 2018 | 0.61x | $272.64K | $447.98K | ▲ +193.7% |
| 2017 | -0.65x | $-284.62K | $438.34K | ▼ -104.9% |
| 2016 | -0.32x | $-143.56K | $453.10K | ▲ +84.7% |
| 2015 | -2.07x | $-1.02 Million | $490.76K | ▲ +21.5% |
| 2014 | -2.64x | $-1.06 Million | $402.56K | ▼ -508.8% |
| 2013 | -0.43x | $-181.61K | $418.72K | ▲ +16.2% |
| 2012 | -0.52x | $-21.47K | $41.47K | ▲ +96.1% |
| 2011 | -13.23x | $-46.30K | $3.50K | — |